华尔街顶级分析师对这些顶尖公司改变了他们的展望。有关所有分析师评级变动的完整视图，包括上调和下调，请查看我们的 分析师评级页面。
<ul>
<li>Baird 将 CrowdStrike Holdings Inc. (NASDAQ: CRWD) 的目标价从 $460 上调至 $490，同时维持中性评级。CrowdStrike Holdings 的股票周一收于 $782.17。查看其他分析师对该股票的看法。</li>
<li>HC Wainwright &amp; Co. 将 Fulcrum Therapeutics Inc. (NASDAQ: FULC) 的目标价从 $25 下调至 $3，并将该股票评级从买入下调至中性。Fulcrum Therapeutics 的股票周一收于 $6.42。查看其他分析师对该股票的看法。</li>
<li>高盛将 HP Inc. (NYSE: HPQ) 的目标价从 $16 上调至 $19，同时维持卖出评级。HP 的股票周一收于 $29.34。查看其他分析师对该股票的看法。</li>
<li>HC Wainwright &amp; Co. 将 Praxis Precision Medicines Inc. (NASDAQ: PRAX) 的目标价从 $1,250 下调至 $1,200，并维持买入评级。Praxis Precision Medicines 的股票周一收于 $335.16。查看其他分析师对该股票的看法。</li>
<li>Ascendiant Capital 将 Genasys Inc. (NASDAQ: GNSS) 的目标价从 $5.50 上调至 $6，并维持买入评级。Genasys 的股票周一收于 $2.11。查看其他分析师对该股票的看法。</li>
<li>高盛将 Intuit Inc. (NASDAQ: INTU) 的目标价从 $519 下调至 $276，并将该股票评级从中性下调至卖出。Intuit 的股票周一收于 $353.76。查看其他分析师对该股票的看法。</li>
<li>Evercore ISI Group 将 Guardant Health Inc. (NASDAQ: GH) 的目标价从 $95 上调至 $160，并将该股票评级从持平上调至跑赢大盘。Guardant Health 的股票周一收于 $129.14。查看其他分析师对该股票的看法。</li>
<li>Needham 将 Credo Technology Group Holding Ltd. (NASDAQ: CRDO) 的目标价从 $220 上调至 $275，同时维持买入评级。Credo Technology Group Holding 的股票周一收于 $226.10。查看其他分析师对该股票的看法。</li>
<li>BTIG 将 Praxis Precision Medicines Inc. (NASDAQ: PRAX) 的目标价从 $843 下调至 $810，并维持买入评级。Praxis Precision Medicines 的股票周一收于 $335.16。查看其他分析师对该股票的看法。</li>
<li>BofA Securities 将 Nu Holdings Ltd. (NYSE: NU) 的目标价从 $16 下调至 $10，并将该股票评级从中性下调至表现不佳。Nu Holdings 的股票周一收于 $12.99。查看其他分析师对该股票的看法。</li>
</ul>

财捷

CRDO

惠普

PRAX

FULC

CRWD

华尔街分析师更新了几只股票的评级和目标价。Baird 将 CrowdStrike 的目标价上调至 490 美元；高盛将惠普的目标价上调至 19 美元，但将 Intuit 的目标价下调至 276 美元并给予降级。HC Wainwright 将 Fulcrum Therapeutics 的评级下调至中性，目标价为 3 美元。Evercore ISI 将 Guardant Health 的评级上调至跑赢大盘，目标价提高至 160 美元。Needham 将 Credo Technology 的目标价提高至 275 美元。BTIG 略微下调了 Praxis Precision Medicines 的目标价，而美银则将 NU Holdings 的评级下调至跑输大盘，目标价为 10 美元

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
<div class="lb-trans">华尔街顶级分析师对这些顶尖公司改变了他们的展望。有关所有分析师评级变动的完整视图，包括上调和下调，请查看我们的 分析师评级页面。
</div><ul>
<li>Baird raised the price target for CrowdStrike Holdings Inc. (NASDAQ: CRWD) from $460 to $490 while maintaining a Neutral rating. CrowdStrike Holdings shares closed at $782.17 on Monday. See how other analysts view this stock.</li>
<li>HC Wainwright &amp; Co. lowered the price target for Fulcrum Therapeutics Inc. (NASDAQ: FULC) from $25 to $3 and downgraded the stock from Buy to Neutral. Fulcrum Therapeutics shares closed at $6.42 on Monday. See how other analysts view this stock.</li>
<li>Goldman Sachs raised the price target for HP Inc. (NYSE: HPQ) from $16 to $19 while maintaining a Sell rating. HP shares closed at $29.34 on Monday. See how other analysts view this stock.</li>
<li>HC Wainwright &amp; Co. cut the price target for Praxis Precision Medicines Inc. (NASDAQ: PRAX) from $1,250 to $1,200 and maintained a Buy rating. Praxis Precision Medicines shares closed at $335.16 on Monday. See how other analysts view this stock.</li>
<li>Ascendiant Capital raised its price target for Genasys Inc. (NASDAQ: GNSS) from $5.50 to $6 and maintained a Buy rating. Genasys shares closed at $2.11 on Monday. See how other analysts view this stock.</li>
<li>Goldman Sachs lowered the price target for Intuit Inc. (NASDAQ: INTU) from $519 to $276 and downgraded the stock from Neutral to Sell. Intuit shares closed at $353.76 on Monday. See how other analysts view this stock.</li>
<li>Evercore ISI Group raised the price target for Guardant Health Inc. (NASDAQ: GH) from $95 to $160 and upgraded the stock from In-Line to Outperform. Guardant Health shares closed at $129.14 on Monday. See how other analysts view this stock.</li>
<li>Needham increased the price target for Credo Technology Group Holding Ltd. (NASDAQ: CRDO) from $220 to $275 while maintaining a Buy rating. Credo Technology Group Holding shares closed at $226.10 on Monday. See how other analysts view this stock.</li>
<li>BTIG lowered its price target for Praxis Precision Medicines Inc. (NASDAQ: PRAX) from $843 to $810 and maintained a Buy rating. Praxis Precision Medicines shares closed at $335.16 on Monday. See how other analysts view this stock.</li>
<li>BofA Securities cut the price target for Nu Holdings Ltd. (NYSE: NU) from $16 to $10 and downgraded the stock from Neutral to Underperform. Nu Holdings shares closed at $12.99 on Monday. See how other analysts view this stock.</li>
</ul>
<div class="lb-trans"><ul>
<li>Baird 将 CrowdStrike Holdings Inc. (NASDAQ: CRWD) 的目标价从 $460 上调至 $490，同时维持中性评级。CrowdStrike Holdings 的股票周一收于 $782.17。查看其他分析师对该股票的看法。</li>
<li>HC Wainwright &amp; Co. 将 Fulcrum Therapeutics Inc. (NASDAQ: FULC) 的目标价从 $25 下调至 $3，并将该股票评级从买入下调至中性。Fulcrum Therapeutics 的股票周一收于 $6.42。查看其他分析师对该股票的看法。</li>
<li>高盛将 HP Inc. (NYSE: HPQ) 的目标价从 $16 上调至 $19，同时维持卖出评级。HP 的股票周一收于 $29.34。查看其他分析师对该股票的看法。</li>
<li>HC Wainwright &amp; Co. 将 Praxis Precision Medicines Inc. (NASDAQ: PRAX) 的目标价从 $1,250 下调至 $1,200，并维持买入评级。Praxis Precision Medicines 的股票周一收于 $335.16。查看其他分析师对该股票的看法。</li>
<li>Ascendiant Capital 将 Genasys Inc. (NASDAQ: GNSS) 的目标价从 $5.50 上调至 $6，并维持买入评级。Genasys 的股票周一收于 $2.11。查看其他分析师对该股票的看法。</li>
<li>高盛将 Intuit Inc. (NASDAQ: INTU) 的目标价从 $519 下调至 $276，并将该股票评级从中性下调至卖出。Intuit 的股票周一收于 $353.76。查看其他分析师对该股票的看法。</li>
<li>Evercore ISI Group 将 Guardant Health Inc. (NASDAQ: GH) 的目标价从 $95 上调至 $160，并将该股票评级从持平上调至跑赢大盘。Guardant Health 的股票周一收于 $129.14。查看其他分析师对该股票的看法。</li>
<li>Needham 将 Credo Technology Group Holding Ltd. (NASDAQ: CRDO) 的目标价从 $220 上调至 $275，同时维持买入评级。Credo Technology Group Holding 的股票周一收于 $226.10。查看其他分析师对该股票的看法。</li>
<li>BTIG 将 Praxis Precision Medicines Inc. (NASDAQ: PRAX) 的目标价从 $843 下调至 $810，并维持买入评级。Praxis Precision Medicines 的股票周一收于 $335.16。查看其他分析师对该股票的看法。</li>
<li>BofA Securities 将 Nu Holdings Ltd. (NYSE: NU) 的目标价从 $16 下调至 $10，并将该股票评级从中性下调至表现不佳。Nu Holdings 的股票周一收于 $12.99。查看其他分析师对该股票的看法。</li>
</ul>
</div>

CrowdStrike 将上涨 7%？以下是周二的十大分析师预测